Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,066) Arrow Down
Filter Results: (2,066) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (2,066)
    • People  (5)
    • News  (553)
    • Research  (1,095)
    • Events  (1)
    • Multimedia  (4)
  • Faculty Publications  (401)

Show Results For

  • All HBS Web  (2,066)
    • People  (5)
    • News  (553)
    • Research  (1,095)
    • Events  (1)
    • Multimedia  (4)
  • Faculty Publications  (401)
← Page 19 of 2,066 Results →
  • November 2012
  • Case

New Balance Athletic Shoe, Inc. (Abridged)

By: H. Kent Bowen, Robert S. Huckman, Carin-Isabel Knoop and Matthew Preble
Considers whether New Balance, one of the world's five largest manufacturers of athletic footwear, should respond to Adidas' planned acquisition of Reebok—a transaction that would join the second- and third-largest companies in the industry. Highlights the unique... View Details
Keywords: Production; Competitive Strategy; Supply Chain; Brands and Branding; Apparel and Accessories Industry; Sports Industry; Retail Industry; Asia; United States
Citation
Educators
Purchase
Related
Bowen, H. Kent, Robert S. Huckman, Carin-Isabel Knoop, and Matthew Preble. "New Balance Athletic Shoe, Inc. (Abridged)." Harvard Business School Case 613-006, November 2012.
  • 02 Apr 2010
  • What Do You Think?

Why Are Fewer and Fewer U.S. Employees Satisfied With Their Jobs?

covered together during that time, especially several of you who have responded to more than half of the topics (and to C. J. Cullinane who has offered views on nearly every one). This month's column yielded many hypotheses to explain why... View Details
Keywords: by Jim Heskett
  • 14 Jun 2023
  • Research & Ideas

Four Steps to Building the Psychological Safety That High-Performing Teams Need

Perks like remote work or unlimited vacation time might be nice, but when it comes to true fulfillment in a post-pandemic workscape, psychological safety is essential. Harvard Business School Professor Amy C. Edmondson coined the term... View Details
Keywords: by Kara Baskin
  • August 1985
  • Case

CML Group, Inc.: Going Public (C)

By: William A. Sahlman
Contains a description of some issues confronting management of CML Group. They have decided to go public, have selected an underwriting team, and must make final decisions about the size, composition and pricing of the issue. Because stock prices have fallen since the... View Details
Keywords: Initial Public Offering; Going Public; Problems and Challenges; Consumer Products Industry; Retail Industry
Citation
Educators
Purchase
Related
Sahlman, William A. "CML Group, Inc.: Going Public (C)." Harvard Business School Case 286-009, August 1985.
  • 24 Jun 2013
  • Working Paper Summaries

The Entrepreneurial Gap: How Managers Adjust Span of Accountability and Span of Control to Implement Business Strategy

Keywords: by Robert L. Simons
  • 2017
  • Working Paper

Firm Selection and Corporate Cash Holdings

By: Juliane Begenau and Berardino Palazzo
Among stock market entrants, more firms over time are R&D intensive with initially lower profitability but higher growth potential. This sample-selection effect determines the secular trend in U.S. public firms’ cash holdings. A stylized firm industry model allows us... View Details
Keywords: Initial Public Offering; Market Entry and Exit; Supply and Industry; Research and Development
Citation
SSRN
Read Now
Related
Begenau, Juliane, and Berardino Palazzo. "Firm Selection and Corporate Cash Holdings." NBER Working Paper Series, No. 23249, March 2017. (Revised February 2017. Harvard Business School Working Paper, No. 16-130, May 2016)
  • Article

Corporate Headquarters in the Twenty-first Century: An Organization Design Perspective

By: Sven Kunisch, Markus Menz and David J. Collis
The corporate headquarters (CHQ) of the multi-business enterprise, which emerged as the dominant organizational form for the conduct of business in the twentieth century, has attracted considerable scholarly attention. As the business environment undergoes a... View Details
Keywords: Corporate Strategy; Organizational Design; Organizational Structure; Business Headquarters
Citation
Read Now
Related
Kunisch, Sven, Markus Menz, and David J. Collis. "Corporate Headquarters in the Twenty-first Century: An Organization Design Perspective." Art. 22. Journal of Organization Design 9 (2020): 1–32.
  • 29 Feb 2016
  • HBS Case

Bigbelly's Big Bet on the Digital Trash Can

Weiss, a former chief of staff for the mayor of Boston, who now teaches a course at HBS on public entrepreneurship. Hard sell Weiss initially approached Bigbelly looking for a non-technology case about how companies selling to government... View Details
Keywords: by Michael Blanding; Energy
  • 19 Jan 2021
  • In Practice

Leadership Advice for Biden: Restore a Sense of Calm

missed this opportunity in the aftermath of the financial crisis, let’s hope that we will not miss this opportunity this time around. Julie Battilana (@julie_battilana) is the Joseph C. Wilson Professor of Business Administration at HBS and founder of the Social... View Details
Keywords: by Dina Gerdeman
  • January 2023
  • Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
  • January 2017 (Revised October 2018)
  • Case

Novartis: A Transformative Deal

By: David Collis and Ashley Hartman
When Joe Jimenez became CEO of Swiss-based Novartis in 2010, replacing longtime CEO Dan Vasella, he assumed control of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and... View Details
Keywords: Novartis; GlaxoSmithKline; Asset Swap; Acquisitions; Divestiture; Strategy Alignment; Pharmaceuticals; Strategy; Business Strategy; Corporate Strategy; Diversification; Consolidation; Mergers and Acquisitions; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Collis, David, and Ashley Hartman. "Novartis: A Transformative Deal." Harvard Business School Case 717-453, January 2017. (Revised October 2018.)
  • December 2005
  • Case

IBM and Eclipse (A)

IBM faces a collective action problem: It open sourced its $40 million application platform and has to convince other companies to contribute. Explores the events leading up to IBM's decision to make the Eclipse platform available as an Open Source project. In 1998,... View Details
Keywords: Digital Platforms; Open Source Distribution; Cooperation; Adoption; Computer Industry; Information Technology Industry
Citation
Find at Harvard
Related
O'Mahony, Siobhan, Fernando Cela Diaz, and Evangelos Mamas. "IBM and Eclipse (A)." Harvard Business School Case 906-007, December 2005.

    The De Beers Group: Exploring the Diamond Reselling Opportunity

    In September 2014, Tom Montgomery (SVP of Strategic Initiatives at the De Beers Group) and his team launched a pilot program in the United States to explore the opportunity to sell pre-owned (recycled) diamonds--current sales were estimated to be approximately $1... View Details

    • 10 Sep 2010
    • Working Paper Summaries

    The Impact of Corporate Social Responsibility on Investment Recommendations

    Keywords: by Ioannis Ioannou & George Serafeim; Financial Services
    • January – February 2011
    • Article

    Are You a Good Boss-Or a Great One?

    By: Linda A. Hill and Kent Lineback
    Private moments of doubt and fear come even to managers who have spent years on the job. Any number of events can trigger them: an initiative is going poorly; you get a lukewarm performance review; your new assignment is daunting. HBS professor Linda Hill and executive... View Details
    Keywords: Leadership; Growth and Development Strategy; Management Analysis, Tools, and Techniques; Personal Development and Career; Groups and Teams; Power and Influence; Social and Collaborative Networks
    Citation
    Find at Harvard
    Purchase
    Related
    Hill, Linda A., and Kent Lineback. "Are You a Good Boss-Or a Great One?" Harvard Business Review 89, nos. 1-2 (January–February 2011).
    • September 2008 (Revised June 2013)
    • Case

    Odyssey Healthcare

    By: Robert F. Higgins, Virginia Fuller and Umer Raffat
    In January 2001, Dick Burnham, CEO of Odyssey Healthcare, and Odyssey's Board of Directors were considering selling the hospice care company to a larger provider or making an initial public offering (IPO). With 38 hospice locations in 21 states, Odyssey had been... View Details
    Keywords: Liquidity; Venture Creation/development; Hospice; Venture Capital; Financial Liquidity; Business Exit or Shutdown; Business Growth and Maturation; Business Plan; Entrepreneurship; Health Industry; United States
    Citation
    Educators
    Purchase
    Related
    Higgins, Robert F., Virginia Fuller, and Umer Raffat. "Odyssey Healthcare." Harvard Business School Case 809-052, September 2008. (Revised June 2013.)
    • Web

    Faculty & Advisors | MBA

    Biosciences. He played an integral role in the company’s $85 million initial public offering (IPO) and private Series B and C fundraising rounds. At Celgene, he executed over a dozen deals with a total value... View Details
    • 22 Aug 2005
    • Research & Ideas

    Balancing the Future Against Today’s Needs

    Urquhart, GE Commercial Finance Stanford Graduate School of Business professor Charles A. O'Reilly III and Harvard Business School professor Michael L. Tushman outline one approach in their Harvard Business Review article, "The Ambidextrous Organization"... View Details
    Keywords: by Paul Michelman
    • 02 Jul 2024
    • Book

    Five Essential Elements to Build the Capital You Need to Lead

    will allow you to bring your whole self and the value that you have to offer to your journey, whether that's in work, with family, or in the community. “Our being best friends was a cultural ingredient in how well we were able to work... View Details
    Keywords: by Dina Gerdeman
    • 11 Feb 2015
    • Research & Ideas

    Politicians Benefited From Using Toxic Loans

    Talk of the recent financial crisis often falls into a simplistic narrative of villainous banks, marketing toxic financial products to innocent customers who did not understand their risks. Among the storied victims are municipal governments that took out loans with... View Details
    Keywords: by Carmen Nobel; Financial Services
    • ←
    • 19
    • 20
    • …
    • 103
    • 104
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.